
NanoViricides NNVC
€ 0.79
-5.59%
Quartalsbericht 2025-Q4
hinzugefügt 17.02.2026
NanoViricides P/CF 2011-2026 | NNVC
P/CF Jährlich NanoViricides
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.53 | -2.73 | -2.48 | -3.31 | -3.98 | -5.18 | -2.4 | -3.08 | -11 | -13.8 | -6.54 | -18.3 | -25.8 | -16.8 | -34.6 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.4 | -34.6 | -10.2 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Verastem
VSTM
|
-2.94 | $ 5.04 | -4.73 % | $ 349 M | ||
|
VistaGen Therapeutics
VTGN
|
-1.75 | $ 0.57 | -5.87 % | $ 17.6 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.68 K | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
-54 | $ 12.41 | -11.1 % | $ 1.88 B | ||
|
Xenon Pharmaceuticals
XENE
|
-16.5 | $ 54.48 | -1.89 % | $ 4.24 B | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
ChemoCentryx
CCXI
|
-0.024 | - | - | $ 3.74 B | ||
|
Enochian Biosciences
ENOB
|
-14.7 | - | - | $ 40.5 M | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Summit Therapeutics
SMMT
|
-37.2 | $ 16.58 | -3.94 % | $ 12.4 B | ||
|
Bellerophon Therapeutics
BLPH
|
-4.42 | - | -74.18 % | $ 955 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
77.9 | $ 317.36 | -3.29 % | $ 41.6 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-21.4 | $ 4.29 | -3.6 % | $ 822 M | ||
|
Allakos
ALLK
|
-0.976 | - | - | $ 28.6 M | ||
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | ||
|
Calithera Biosciences
CALA
|
-14.5 | - | -10.95 % | $ 876 K | ||
|
Fusion Pharmaceuticals
FUSN
|
-16.9 | - | - | $ 1.41 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
8 | $ 19.01 | -2.66 % | $ 889 M | ||
|
Gritstone Oncology
GRTS
|
-2.27 | - | 0.42 % | $ 213 M | ||
|
Завод ДИОД
DIOD
|
7.49 | - | - | - | ||
|
Фармсинтез
LIFE
|
-8.26 | - | - | - | ||
|
ACADIA Pharmaceuticals
ACAD
|
20.2 | $ 20.75 | -3.35 % | $ 3.44 B | ||
|
Aligos Therapeutics
ALGS
|
-0.799 | $ 6.66 | -5.4 % | $ 65.8 M | ||
|
Teligent, Inc.
TLGT
|
-0.3 | - | -13.85 % | $ 16.1 M | ||
|
Viela Bio, Inc.
VIE
|
-3.37 | - | - | $ 2.91 B | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Alkermes plc
ALKS
|
9.85 | $ 29.39 | -1.77 % | $ 4.84 B | ||
|
Cabaletta Bio
CABA
|
-2.16 | $ 2.68 | -4.96 % | $ 269 M | ||
|
AbbVie
ABBV
|
21 | $ 209.4 | -0.81 % | $ 370 B | ||
|
AbCellera Biologics
ABCL
|
-7.33 | $ 3.27 | -2.39 % | $ 977 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Athira Pharma
ATHA
|
-0.166 | - | - | $ 269 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M |